New routes in frontotemporal dementia drug discovery

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Frontotemporal dementia (FTD) research has identified new therapeutic targets.
• These targets include pathways affected by mutations and protein aggregate dynamics.

Purpose of the Study:

• To outline the principal molecular causes of FTD.
• To review research on corrective strategies for FTD.
• To provide expert opinion on the most promising therapeutic approaches.

Main Methods:

• Literature review of pathogenic mechanisms in FTD.
• Analysis of mutation-driven pathways.
• Evaluation of protein aggregate modulation, formation, and degradation.

Main Results:

• Targeting pathways affected by specific FTD mutations is valuable but faces challenges.
• Remaining protein aggregates and lack of universal applicability hinder current treatments.
• Downstream functional recovery is insufficient due to complex event cascades.

Conclusions:

• Clearance of protein aggregates is a more appropriate therapeutic strategy for FTD.
• Inhibition of protein misfolding represents a direct route to FTD therapy.
• Future FTD treatments should prioritize aggregate clearance and misfolding inhibition.